Effect of Highly Active Antiretroviral Therapy on the Incidence and Clinical Manifestations of Visceral Leishmaniasis in Human Immunodeficiency Virus--Infected Patients | Zendy

M. Cotarelo | Zendy; J. Alfredo Martínéz | Zendy; J.M. Guerra Vales | Zendy; Pilar MartínezSánchez | Zendy; Mariano Bárcena | Zendy; E. S. Fernandez | Zendy

Open Access

Effect of Highly Active Antiretroviral Therapy on the Incidence and Clinical Manifestations of Visceral Leishmaniasis in Human Immunodeficiency Virus--Infected Patients

Author(s) -

M. Cotarelo,

J. Alfredo Martínéz,

J.M. Guerra Vales,

Pilar MartínezSánchez,

Mariano Bárcena,

E. S. Fernandez

Publication year - 2003

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/377607

Subject(s) - visceral leishmaniasis , medicine , incidence (geometry) , leishmaniasis , antiretroviral therapy , immunology , sida , viral disease , human immunodeficiency virus (hiv) , immunopathology , virology , viral load , physics , optics

This study analyzes the effect of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in human immunodeficiency virus-infected individuals. We describe 66 episodes diagnosed in our hospital from 1994 through 2000 (35 episodes in patients who were not receiving HAART and 31 episodes in patients who were receiving HAART). Since HAART became available, the incidence of visceral leishmaniasis has significantly decreased and the number of first episodes has decreased, although the number of relapses is increasing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research